Evidence map›Paper›PMID 26733813›Full record

ArticleFrontiers in cellular neuroscience2015

Gliopathy of Demyelinating and Non-Demyelinating Strains of Mouse Hepatitis Virus.

Lawrence C Kenyon, Kaushiki Biswas, Kenneth S Shindler, Manasi Nabar, Marjorie Stout, Susan T Hingley, Judith B Grinspan, Jayasri Das Sarma

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Lawrence C KenyonDepartment of Pathology, Anatomy and Cell Biology, Thomas Jefferson University Philadelphia, PA, USA.
Kaushiki BiswasDepartment of Biological Sciences, Indian Institute of Science Education and Research Kolkata, India.
Kenneth S ShindlerScheie Eye Institute and FM Kirby Center for Molecular Ophthalmology, University of Pennsylvania Philadelphia, PA, USA.
Manasi NabarDepartment of Neurology, Thomas Jefferson University Philadelphia, PA, USA.
Marjorie StoutDepartment of Neurology, Thomas Jefferson University Philadelphia, PA, USA.
Susan T HingleyDepartment of Microbiology, Philadelphia College of Osteopathic Medicine Philadelphia, PA, USA.
Judith B GrinspanDepartment of Neurology, Children's Hospital of Philadelphia Philadelphia, PA, USA.
Jayasri Das SarmaDepartment of Pathology, Anatomy and Cell Biology, Thomas Jefferson UniversityPhiladelphia, PA, USA; Department of Biological Sciences, Indian Institute of Science Education and ResearchKolkata, India; Department of Neurology, Thomas Jefferson UniversityPhiladelphia, PA, USA.
Thomas Jefferson University · USIndian Institute of Science Education and Research Kolkata · INChildren's Hospital of Philadelphia · USPhiladelphia College of Osteopathic Medicine · USUniversity of Pennsylvania · US

Funding

The Intellectual and Developmental Disabilities Research Center at CHOP/PennU54HD086984 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI YUDKOFF, MARC · 2016 to 2020
$6.3M
Mechanism of SIRT1 Activator Mediated Neuroprotection of Retinal Ganglion CellsR01EY019014 · NEI · UNIVERSITY OF PENNSYLVANIA · PI SHINDLER, KENNETH S · 2010 to 2020
$3.7M
NEI NIH HHS R01 EY019014NICHD NIH HHS U54 HD086984
6 · The paper itself

Abstract

Demyelination in the central nervous system induced by neurovirulent strains of Mouse Hepatitis Virus (MHV) is mediated by the viral spike glycoprotein, but it is not clear whether the mechanism of this disease pathology involves direct viral infection of oligodendrocytes. Detailed studies of glial cell tropism of MHV are presented, demonstrating that direct MHV infection of oligodendrocytes differs between demyelinating (RSA59) and non-demyelinating (RSMHV2) viral strains both in vitro and in vivo. Our results indicate that direct injury of mature oligodendrocytes is an important mechanism of virus-induced demyelination. In vivo, RSA59 infection was identified in spinal cord gray and white matter, but infected oligodendrocytes were restricted to white matter. In contrast, RSMHV2 infection was restricted to gray matter neurons and was not localized to oligodendrocytes. In vitro, RSA59 can infect both oligodendrocyte precursors and differentiated oligodendrocytes, whereas RSMHV2 can infect oligodendrocyte precursors but not differentiated oligodendrocytes. Viral spreading through axonal means to white matter and release of the demyelinating strain MHV at the nerve end is critical for oligodendrocytes infection and subsequent demyelination. Understanding the mechanisms by which known viruses effect demyelination in this animal model has important therapeutic implications in the treatment of human demyelinating disease.

Indexed as

astrocytesdemyelinationmouse hepatitis virusmultiple sclerosisoligodendrocytesvirus host attachment spike protein

Identifiers

PMID26733813
PMCPMC4686739
OpenAlexW2222163236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.